Primary Site >> Colorectal Cancer
Gene >> PSG2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Cancer markers in patients receiving chemotherapy for colorectal cancer: a preliminary report. PMID: 34085 |
Ref: Further characterization of CSAp, an antigen associated with gastrointestinal and ovarian tumors. PMID: 81713 Ref: [beta2-Microglobulin in cancer patients (author's transl)]. PMID: 83577 Ref: A critical comparison of the value of pregnancy-associated alpha2-glycoprotein and carcinoembryonic antigen assays in patients with colorectal cancer. PMID: 84001 |
Ref: Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer. PMID: 371789 |
Ref: Tumor-associated antigens in polyps and carcinoma of the human large bowel. PMID: 6164469 Ref: Significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast, gastric and colorectal cancer. PMID: 6175310 |
Ref: Predictive value of plasma CEA levels: preoperative prognosis and postoperative monitoring of patients with colorectal carcinoma. PMID: 6173181 |
Ref: Protracted ambulatory venous infusion of 5-fluorouracil. PMID: 6837501 Ref: The strongest prognostic factors in colorectal carcinoma. Surgicopathologic stage of disease and postoperative fever. PMID: 6839898 Ref: Colorectal carcinoma. Evidence for circulating CEA-anti-CEA complexes. PMID: 6850537 Ref: Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas. PMID: 6852972 |
Ref: [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker]. PMID: 6201629 |
Ref: Human pancreatic cancer associated antigen detected by monoclonal antibody. PMID: 3515631 |
Ref: Diverse characteristics of 111In labelled anti-CEA monoclonal antibodies for tumour immunoscintigraphy: radiolabelling, biodistribution and imaging studies in mice with human tumour xenografts. PMID: 3569340 |
Ref: Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125. PMID: 3230337 |
Ref: [Chemoembolization with degradable starch microspheres for liver metastases in colorectal cancer]. PMID: 2506828 Ref: [Clinical evaluation of second-look operations in colorectal cancer]. PMID: 2658821 Ref: The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant tumors. PMID: 2703054 Ref: [Hepatic arterial infusion chemotherapy using totally implantable reservoir in liver metastases in colorectal cancer]. PMID: 2782894 Ref: Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients. PMID: 2810823 |
Ref: [Tumor markers in liver metastases of colorectal carcinoma]. PMID: 1980590 Ref: Ultrasonic endoluminal examination in the follow-up of colorectal cancer. Initial experience and results. PMID: 2286800 Ref: Radiolabelled monoclonal antibodies in tumour diagnosis and therapy. PMID: 2401391 Ref: Immunohistochemical analysis of the relationship between CEA localization and mononuclear cell infiltration in human colorectal carcinoma. PMID: 2406506 |
Ref: [Sensitivity and specificity of alpha-1-antitrypsin and acid alpha-1-glycoprotein in colorectal carcinoma]. PMID: 1725848 Ref: [Production and characterization of monoclonal antibody against colon cancer associated antigen in Chinese]. PMID: 1848460 Ref: [Intra-arterial infusion chemotherapy using an implantable reservoir in the treatment of hepatic metastases in colorectal cancer]. PMID: 1908659 Ref: [Splenic or hepatic arterial injections of interleukin-2 with chemotherapeutic agents for hepatic metastases]. PMID: 1944193 Ref: DNA flow cytometry of colorectal carcinoma: correlation of DNA stemlines with other prognostic indices. PMID: 1992633 |
Ref: CEA and NCA expressed by colon carcinoma cells affect their interaction with and lysability by activated lymphocytes. PMID: 1431336 Ref: [Therapeutic results of intra-arterial infusion chemotherapy using an implantable reservoir on metastatic liver tumors]. PMID: 1530299 Ref: Clinical trials of intrasplenic arterial infusion of interleukin-2 (IS-IL-2) to patients with advanced cancer. PMID: 1622739 |
Ref: Determination of the specificities of monoclonal antibodies recognizing members of the CEA family using a panel of transfectants. PMID: 7690348 Ref: Estimated treatment responses in metastatic colorectal carcinoma based on longitudinal carcinoembryonic antigen series. PMID: 8140393 Ref: [A case of pulmonary metastasis from colon cancer successfully treated by 5-FU combined with leucovorin and interferon alpha-2a]. PMID: 8239693 Ref: Radioimmunoscintigraphy of advanced gastrointestinal carcinomas employing I-131 labeled CEA-79 monoclonal antibody. PMID: 8318349 Ref: Immunoscintigraphy in colorectal cancer: surgeon's perspective. PMID: 8366298 Ref: [Radioimmunoscintimetry for intraoperative lymph node diagnosis in colorectal cancer]. PMID: 8474294 |
Ref: Serum c-erbB-2 oncoprotein in the diagnosis of gastric cancer in comparison with CA 19-9, CEA, TPA, CA 125 and AFP. PMID: 7525029 Ref: Serum soluble interleukin-2 receptor in colorectal cancer. PMID: 8142118 Ref: Anti-idiotypic monoclonal antibody AB3, reacting with the primary antigen (CEA), can localize in human colon-carcinoma xenografts as efficiently as AB1. PMID: 8181861 |
Ref: Feasibility of radioimmunoguided surgery of colorectal carcinoma using indium 111 CEA specific antibody and simulation with a phantom using 2 steps targetting with bispecific antibody. PMID: 7571036 Ref: Urinary organ specific neoantigen. A potentially diagnostic test for colorectal cancer. PMID: 7628279 Ref: The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9 and C-erb B-2, beta HCG immunohistochemistry in advanced colorectal cancer. PMID: 8573538 |
Ref: Soluble interleukin-2 receptors in patients with advanced colorectal carcinoma. PMID: 8740635 Ref: [Diagnosis and therapy for metastatic liver cancer]. PMID: 8831736 Ref: False tumor-positive lymph nodes in radioimmunodiagnosis and radioimmunoguided surgery: etiologic mechanisms. PMID: 8841463 Ref: [Tumor associated biomarker for early diagnosis of cancer]. PMID: 8965352 Ref: Antiinvasive effects of Tiazofurin on liver-metastatic human colon carcinoma xenografts. PMID: 9042307 |
Ref: Adoptive immunotherapy as an in vivo model to explore antitumor mechanisms induced by a recombinant anticancer vaccine. PMID: 9101413 Ref: Comparison of copper-67- and iodine-125-labeled anti-CEA monoclonal antibody biodistribution in patients with colorectal tumors. PMID: 9189128 Ref: Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. PMID: 9252706 |
Ref: Resistance of the human colon carcinoma cell line HCT-8 to methotrexate results in selection of cells with features of enterocytic differentiation. PMID: 9495241 Ref: Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma. PMID: 9522212 Ref: [Percutaneous ethanol and acetic acid injection for liver metastasis from colon cancer--two case reports]. PMID: 9571976 Ref: Preparation and characterization of differently aggregated colorectal carcinoma cell subpopulations from surgical specimens. PMID: 9674875 Ref: Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer. PMID: 9754756 Ref: Endogenous TNF induction therapy using rTNF-SAM2 in patients with pulmonary metastases from colorectal cancer. PMID: 9854506 Ref: Colorectal follow-up planning modified on the basis of our personal experience. PMID: 9867442 Ref: [The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma]. PMID: 9974027 Ref: [Expression and significance of p53, c-erbB2, CEA proteins in colorectal adenoma and carcinoma]. PMID: 10681823 Ref: [Liver metastasis models of human colo-rectal carcinoma established in nude mice by orthotopic transplantation and their biologic characteristics]. PMID: 10920954 Ref: [Experimental treatment for human colorectal carcinoma by tissue type specific expression of herpes simplex virus thymidine kinase gene]. PMID: 12016970 |
Ref: Characterization of lectin resistant cell populations derived from human colon carcinoma: correlation of K-Ras with beta1-6 branching of N-linked carbohydrate and CEA production. PMID: 10364462 Ref: Tumor-specific expression of anti-mdr1 ribozyme selectively restores chemosensitivity in multidrug-resistant colon-adenocarcinoma cells. PMID: 10399951 Ref: A case of colon cancer recurrence with P-glycoprotein treated by methotrexate, fluorouracil, and leucovorin. PMID: 10430334 Ref: [Establishment of alpha-fetoprotein producing human rectal cancer cell line (RKK-YK) and its features]. PMID: 10434556 Ref: [Intraarterial infusion therapy for unresectable liver metastasis of colorectal cancer]. PMID: 10560376 |
Ref: Ferumoxide-enhanced MRI in patients with colorectal cancer and rising CEA: surgical correlation in early recurrence. PMID: 10745140 Ref: CEA is the major PHA-L-reactive glycoprotein in colon carcinoma cell lines and tumors: relationship between K-ras activation and beta1-6 branching of N-linked carbohydrate on CEA. PMID: 10873577 Ref: Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer. PMID: 11044360 Ref: T cell responses in colorectal cancer patients: evidence for class II HLA-restricted recognition of shared tumor-associated antigens. PMID: 11093821 Ref: Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer. PMID: 11326648 |
Ref: Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1. PMID: 11299816 Ref: Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase gene. PMID: 11724328 Ref: Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma. PMID: 11776754 |
Ref: Vinyl sulfone bifunctional derivatives of DOTA allow sulfhydryl- or amino-directed coupling to antibodies. Conjugates retain immunoreactivity and have similar biodistributions. PMID: 11792185 Ref: Current concepts in immunotherapy for the treatment of colorectal cancer. PMID: 12018689 Ref: Results of long-term follow-up after curative resection of Dukes A colorectal cancer. PMID: 12053228 Ref: Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine. PMID: 12100028 Ref: Relationship between degree of cellular differentiation in colorectal cancer and topographical distribution. PMID: 12185656 Ref: [Resection made possible following hepatic arterial infusion in 2 cases of hepatic metastases from colorectal cancer]. PMID: 12484012 |
Ref: Diagnostic value of bone and tumour markers in patients with malignant diseases. PMID: 12820336 Ref: [CEA, CA-19-9 and il-8, sTNFRII and sil-2R in persons at high risk of colorectal cancer]. PMID: 12868194 Ref: A prognostic score for colorectal cancer. PMID: 14571737 Ref: [Usefulness of plasma tumor M2-pyruvate kinase in the diagnosis of gastrointestinal cancer]. PMID: 14646575 Ref: Thermic ablation with RF of liver metastases from colorectal cancer. PMID: 15244179 |
Ref: The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer. PMID: 15028308 Ref: Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls. PMID: 15162541 Ref: Cytotoxic T-cell immunity against telomerase reverse transcriptase in colorectal cancer patients. PMID: 15375515 Ref: Prolonged survival of mice with multiple liver metastases of human colon cancer by intravenous administration of replicable E1B-55K-deleted adenovirus with E1A expressed by CEA promoter. PMID: 15564136 Ref: CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer. PMID: 15627885 Ref: Responsiveness of CPT-11 in respect to hMLH1 and hMSH2 protein expression in the primary colorectal cancer. PMID: 20368829 |
Ref: Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma. PMID: 15586226 Ref: T cell responses against tumor associated antigens and prognosis in colorectal cancer patients. PMID: 15659244 Ref: Loss of heterozygosity: an independent prognostic factor of colorectal cancer. PMID: 15682467 Ref: Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified? PMID: 15816454 Ref: Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study. PMID: 15882879 Ref: Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine. PMID: 15930317 Ref: Differential gene expression profile reveals deregulation of pregnancy specific beta1 glycoprotein 9 early during colorectal carcinogenesis. PMID: 15982419 Ref: Urinary nucleosides as biological markers for patients with colorectal cancer. PMID: 15991285 Ref: Improved sensitivity in the diagnosis of gastro-intestinal tumors by fuzzy logic-based tumor marker profiles including the tumor M2-PK. PMID: 16033052 Ref: Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells. PMID: 16080467 Ref: [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. PMID: 16241086 Ref: [Intra-arterial infusion chemotherapy for advanced cancer--40 years of experience]. PMID: 16315888 |
Ref: Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro. PMID: 16507098 Ref: Diacetylated derivatives of spermine and spermidine as novel promising tumor markers. PMID: 16567395 Ref: Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease. PMID: 16650961 Ref: Prognostic value of circulating KRAS2 gene mutations in colorectal cancer with distant metastases. PMID: 17177160 |
Ref: Preoperative serum levels of c-erbB-2 do not seem to be useful in management of patients with rectal cancer. PMID: 17119985 Ref: Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition. PMID: 17373735 Ref: [Evaluation of cyclooxygenase-2 in the prediction of liver metastasis of colorectal carcinoma]. PMID: 17403293 Ref: Role of tumor markers in patients with solid cancers: A critical review. PMID: 17449388 Ref: The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients. PMID: 17593628 Ref: Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer. PMID: 17649779 Ref: The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers. PMID: 17708279 Ref: [Effect of neoadjuvant chemotherapy on the results of resection of colorectal liver metastases]. PMID: 17916288 Ref: Characterization of antigen-specific immune responses induced by canarypox virus vaccines. PMID: 17947686 |
Ref: Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence. PMID: 18028472 Ref: Elevation in peripheral blood circulating tumor cell number correlates with macroscopic progression in UICC stage IV colorectal cancer patients. PMID: 18334735 Ref: Potential role of bcl-2 expression and apoptotic body index in colorectal cancer. PMID: 18507083 Ref: [Combination chemotherapy composed of mFOLFOX 6, FOLFIRI 2 and surgery and radiation therapy for locoregional recurrences and multiple lung metastases from rectal cancer--a case report]. PMID: 18633265 Ref: Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy. PMID: 18785806 Ref: Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers. PMID: 18932285 Ref: Detection of colorectal cancer cells from feces using quantitative real-time RT-PCR for colorectal cancer diagnosis. PMID: 19016757 Ref: Combined perioperative plasma endoglin and VEGF-A assessment in colorectal cancer patients. PMID: 19141403 |
Ref: [A successfully resected case of rectal cancer with liver metastases treated with mFOLFOX6 and bevacizumab]. PMID: 19381044 Ref: Factors influencing histological response after neoadjuvant chemoradiation therapy for rectal carcinoma. PMID: 19446404 Ref: A practice survey of the evolution of rectal cancer management: a Belgian Federal College of radiotherapy study. PMID: 19617178 Ref: Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination. PMID: 19863224 Ref: Factors influencing prognosis after neo-adjuvant chemoradiation therapy for rectal carcinoma. PMID: 19943591 Ref: N-acetyl-beta-D-hexosaminidase and its isoenzymes A and B in blood serum and urine, as a potential colon cancer markers. PMID: 19950779 Ref: Prognostic evaluation of pT1 and pT2 colorectal cancer. PMID: 19954584 Ref: Combined perioperative plasma endoglin and VEGF--a assessment in colorectal cancer patients. PMID: 19995709 |
Ref: CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma. PMID: 19926591 Ref: Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer. PMID: 20532772 Ref: Dendritic cell vaccination of patients with metastatic colorectal cancer. PMID: 20816019 Ref: Tandem affinity depletion: a combination of affinity fractionation and immunoaffinity depletion allows the detection of low-abundance components in the complex proteomes of body fluids. PMID: 20839810 Ref: Importance of the circumferential extent of tumors and clinical lymph node status as prognostic factors after preoperative chemoradiotherapy and surgery in patients with rectal cancer. PMID: 20968136 Ref: Could tumor characteristics identified by colonoscopy predict the locally advanced rectal carcinoma? PMID: 21034548 Ref: Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients. PMID: 21478099 |
Ref: Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1. PMID: 21076463 Ref: Do young patients with colorectal cancer have a poorer prognosis than old patients? PMID: 21316708 Ref: Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer. PMID: 21541674 Ref: Expression of COX-2, MMP-2 and VEGF in stage II and III colorectal cancer and the clinical significance. PMID: 21661398 Ref: Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease. PMID: 21700179 Ref: Detection of TFPI2 methylation in the serum of colorectal cancer patients. PMID: 21820798 Ref: [Advanced poorly differentiated adenocarcinoma of the colon with micropapillary carcinoma components except specific cytokeratin expressions, report of a case]. PMID: 22139489 Ref: [Three cases of patients in their eighties who received anti-EGFR antibody mono-therapy as first-line treatment for metastatic colorectal cancer]. PMID: 22202343 Ref: A phase II trial of 5-fluorouracil, leucovorin and mitomycin C in patients with advanced gastric cancer. PMID: 22322834 |
Ref: Comparative analysis of tumor markers and evaluation of their predictive value in patients with colorectal cancer. PMID: 22414974 Ref: Identification and functional screening of microRNAs highly deregulated in colorectal cancer. PMID: 22469014 Ref: Association of folate intake, dietary habits, smoking and COX-2 promotor -765G>C polymorphism with K-ras mutation in patients with colorectal cancer. PMID: 22929917 Ref: Multivariate analysis of molecular indicators for postoperative liver metastasis in colorectal cancer cases. PMID: 23098501 Ref: Serum concentrations of human chorionic gonadotropin beta and its association with survival in patients with colorectal cancer. PMID: 23144155 |
Ref: Are oestrogens and genetic predisposition etiologic factors in the development of clear cell carcinoma of the peritoneum? PMID: 23265355 Ref: A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases from colorectal cancer. PMID: 23575907 Ref: Correlations of tumor-associated macrophage subtypes with liver metastases of colorectal cancer. PMID: 23621176 Ref: Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance. PMID: 23726839 Ref: Multiplexed cytokine profiling of serum for detection of colorectal cancer. PMID: 23837764 Ref: CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients. PMID: 23991991 Ref: Prognostic Significance of DR-70 Levels in Dysplastic Colorectal Polyps. PMID: 24348532 |
Ref: An essential microRNA maturing microprocessor complex component DGCR8 is up-regulated in colorectal carcinomas. PMID: 23775303 Ref: Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. PMID: 23852704 Ref: Aberrant SERCA3 expression during the colorectal adenoma-adenocarcinoma sequence. PMID: 24213720 Ref: Extramural depth of tumor invasion at thin-section MR in rectal cancer: associating with prognostic factors and ADC value. PMID: 24307597 Ref: CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. PMID: 24504682 Ref: Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection. PMID: 24608301 Ref: Colon cancer-specific antigen-2 may be used as a detecting and prognostic marker in colorectal cancer: a preliminary observation. PMID: 24710115 Ref: [A case of para-aortic lymph node metastasis from colon cancer with complete response to uracil/tegafur plus leucovorin therapy]. PMID: 24743211 Ref: Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer. PMID: 24746569 Ref: Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients. PMID: 24949322 Ref: The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy. PMID: 25159232 Ref: Drug allergy and the risk of lymph node metastasis in rectal cancer. PMID: 25162236 Ref: High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer. PMID: 25301559 Ref: Rab27b is a potential predictor for metastasis and prognosis in colorectal cancer. PMID: 25580113 Ref: [Curative dissection of paraaortic lymph node metastases after operation for ascending colon cancer]. PMID: 25731270 Ref: [Rectal cancer with local re-recurrence successfully treated by carbon ion radiotherapy]. PMID: 25731304 |
Ref: Prognostic value of poorly differentiated clusters in the primary tumor in patients undergoing hepatectomy for colorectal liver metastasis. PMID: 25731780 Ref: Trefoil factor family (TFF) proteins as potential serum biomarkers in patients with metastatic colorectal cancer. PMID: 25866228 Ref: Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients. PMID: 25889931 Ref: CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes. PMID: 25968046 Ref: A specific KRAS codon 13 mutation is an independent predictor for colorectal cancer metachronous distant metastases. PMID: 25973306 Ref: Expression of lncRNA-CCAT1, E-cadherin and N-cadherin in colorectal cancer and its clinical significance. PMID: 26064266 Ref: Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals. PMID: 26254391 Ref: Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value. PMID: 26617865 Ref: ATAD2 Overexpression Identifies Colorectal Cancer Patients with Poor Prognosis and Drives Proliferation of Cancer Cells. PMID: 26697062 Ref: [Total Pelvic Exenteration for Local Recurrence of Rectal Cancer Appearing 12 Years after Curative Operation--A Case Report]. PMID: 26805356 |
Ref: Clinical value of intratumoral metabolic heterogeneity in [18F]FDG PET/CT for prediction of recurrence in patients with locally advanced colorectal cancer. PMID: 27045576 Ref: High expression of Rab3D predicts poor prognosis and associates with tumor progression in colorectal cancer. PMID: 27046094 Ref: PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. PMID: 27110285 Ref: A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer. PMID: 27384088 Ref: The prognostic significance and treatment modality for elevated pre- and postoperative serum CEA in colorectal cancer patients. PMID: 27757393 Ref: Monitoring of Circulating Tumor Cells by a Combination of Immunomagnetic Enrichment and RT-PCR in Colorectal Cancer Patients Undergoing Surgery. PMID: 28028983 |
Ref: Clinical impact of colonoscopy for patients with early gastric cancer treated by endoscopic submucosal dissection: A matched case-control study. PMID: 27810400 Ref: Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer. PMID: 27836416 Ref: Prognostic value of IRF-2 expression in colorectal cancer. PMID: 28465494 Ref: Diagnostic Performance of a Novel Multiplex Immunoassay in Colorectal Cancer. PMID: 28476816 Ref: Optimization of a multigene biochip for detection of relapsed and early relapsed colorectal cancer. PMID: 28711367 Ref: Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer. PMID: 28801584 Ref: Are All Mutations the Same? A Rare Case Report of Coexisting Mutually Exclusive KRAS and BRAF Mutations in a Patient with Metastatic Colon Adenocarcinoma. PMID: 28811946 Ref: Factors associated with degree of tumour response to neo-adjuvant radiotherapy in rectal cancer and subsequent corresponding outcomes. PMID: 28943178 Ref: RBP4 and THBS2 are serum biomarkers for diagnosis of colorectal cancer. PMID: 29190912 |
Ref: Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer. PMID: 29400662 Ref: Revisiting colorectal cancer animal model - An improved metastatic model for distal rectosigmoid colon carcinoma. PMID: 29628185 Ref: Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma. PMID: 29849497 Ref: [Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer]. PMID: 29936770 Ref: Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study. PMID: 29984382 Ref: Systematic review of blood diagnostic markers in colorectal cancer. PMID: 30022330 Ref: Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis. PMID: 30080722 Ref: Survival outcome of adjuvant radiotherapy after local excision for T2 early rectal cancer: An analysis based on the surveillance, epidemiology, and end result registry database. PMID: 30262325 Ref: Significance of lymph node metastasis in the survival of stage IV colorectal cancer by hematogenous metastasis. PMID: 30310803 Ref: CRP and LOX-1: a Mechanism for Increasing the Tumorigenic Potential of Colorectal Cancer Carcinoma Cell Line. PMID: 30368730 |